Earnings ·
Acadia Healthcare reports Q3 revenue of $895.3M, raises full-year adjusted EPS guidance to $1.70-$1.80
ACHCAcadia Healthcare Company, Inc.
Acadia Healthcare reported third-quarter 2026 revenue of $895.3 million, a 5.1% increase year-over-year, driven by an 11.3% rise in acute inpatient psychiatric facility revenue and the addition of 220 licensed beds. Net income attributable to Acadia was $34.5 million, or $0.38 per diluted share, while adjusted EBITDA reached $176.4 million. The company raised its full-year 2026 financial guidance, increasing adjusted earnings per diluted share expectations to a range of $1.70-$1.80 from the previous $1.45-$1.60 range, and lifted adjusted EBITDA guidance to $615-$625 million. Acadia Healthcare is the largest stand-alone behavioral healthcare company in the United States, operating acute inpatient psychiatric facilities, specialty treatment centers, and residential treatment services.